14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today CDXS ranks #20114 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

$19.83 (-4.62%)

Volume: 782k

Closed: Jan 21, 2022

Hollow Logo Score: -7.886

Codexis Stock Forecast

$19.83 (-4.62%)

Volume: 782k

Closed: Jan 21, 2022

Score Hollow Logo -7.886

Codexis Company Profile

200 Penobscot Drive

Redwood City CA 94063

650-421-8100

www.codexis.com

Industry: Biotechnology

Sector: Healthcare

Codexis

Description

Codexis, Inc. develops biocatalysts for the pharmaceutical and fine chemicals markets in the United States, Europe, Asia, and internationally. The company provides Codex biocatalyst panels and kits to customers that are engaged in drug development and drug manufacturing to allow them to screen and identify possible enzymes that can be applied in the manufacturing processes for their drug candidates and their marketed products. It also offers enzyme screening services and enzyme optimization services; and supplies enzymes, pharmaceutical intermediates, and active pharmaceutical ingredients. In addition, it develops biocatalysts for use in the fine chemicals market, including food and food ingredients, animal feed, flavors and fragrances, and agricultural chemicals. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE